Abstract
Trials on the effect of systemic chemotherapy on survival and recurrence in adults with high-grade glioma have had inconclusive results. We undertook a systematic review and meta-analysis to assess the effects of such treatment on survival and recurrence. We did a systematic review and meta-analysis using updated data on individual patients from all available randomised trials that compared radiotherapy alone with radiotherapy plus chemotherapy. Data for 3004 patients from 12 randomised controlled trials were included (11 published and one unpublished). Overall, the results showed significant prolongation of survival associated with chemotherapy, with a hazard ratio of 0.85 (95% CI 0.78-0.91, p<0.0001) or a 15% relative decrease in the risk of death. This effect is equivalent to an absolute increase in 1-year survival of 6% (95% CI 3-9) from 40% to 46% and a 2-month increase in median survival time (1-3). There was no evidence that the effect of chemotherapy differed in any group of patients defined by age, sex, histology, performance status, or extent of resection. This small but clear improvement in survival from chemotherapy encourages further study of drug treatment of these tumours.
Keywords
MedicineMeta-analysisChemotherapyHazard ratioInternal medicineRadiation therapyRandomized controlled trialGliomaSurvival analysisProportional hazards modelOncologyClinical trialSurgeryConfidence interval
MeSH Terms
AdultCombined Modality TherapyFemaleGliomaHumansMaleMiddle AgedNervous System NeoplasmsRandomized Controlled Trials as TopicSurvival Rate
Affiliated Institutions
Related Publications
Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis Based on Aggregate Data
Purpose This systematic review and meta-analysis were performed to assess the efficacy and tolerability of chemotherapy in patients with advanced gastric cancer. Methods Randomi...
Randomized Trial of Procarbazine, Lomustine, and Vincristine in the Adjuvant Treatment of High-Grade Astrocytoma: A Medical Research Council Trial
PURPOSE: Meta-analyses of the published literature suggest a survival benefit to adjuvant chemotherapy for high-grade astrocytoma, which individual small trials have been unable...
Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review
A systematic review was conducted to develop guidelines for radiotherapy in adult patients with newly diagnosed malignant glioma. MEDLINE, CANCERLIT, the Cochrane Library, and r...
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
In 2004, a randomised phase III trial by the European Organisation for Research and Treatment of Cancer (EORTC) and National Cancer Institute of Canada Clinical Trials Group (NC...
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
The oligometastatic paradigm suggests that some patients with a limited number of metastases might be cured if all lesions are eradicated. Evidence from randomised controlled tr...
Publication Info
- Year
- 2002
- Type
- review
- Volume
- 359
- Issue
- 9311
- Pages
- 1011-1018
- Citations
- 1221
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1221
OpenAlex
22
Influential
969
CrossRef
Cite This
Lesley Stewart
(2002).
Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials.
The Lancet
, 359
(9311)
, 1011-1018.
https://doi.org/10.1016/s0140-6736(02)08091-1
Identifiers
- DOI
- 10.1016/s0140-6736(02)08091-1
- PMID
- 11937180